This is a preview of subscription content, log in via an institution to check access.
Notes
Washington DC, USA
Assuming a conservative first-year market share of 18%, similar to that the cholesterol lowering drug, Lipitor.
Reference
Zuckerman DM, et al. 21st Century Cures Act and similar policy efforts: at what cost? BMJ : 23 Nov 2015. Available from: URL: http://dx.doi.org/10.1136/bmj.h6122
Rights and permissions
About this article
Cite this article
21st Century Cures Act: fast-track to cure or morbidity?. PharmacoEcon Outcomes News 742, 1 (2015). https://doi.org/10.1007/s40274-015-2629-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-015-2629-1